Takeda Pharmaceutical Company Limited
4502
Kedudukan dalam Saham
#375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Harga Saham
$40.45
Modal Pasaran
$64.36B
Perubahan (1 hari)
1.19%
Perubahan (1 tahun)
43.11%
Negara
JP
Perdagangan Takeda Pharmaceutical Company Limited (4502)
Kategori
Healthcare
Sejarah harga saham bagi Takeda Pharmaceutical Company Limited (4502)
Harga penutupan tertinggi: $38.84 pada 2026-10-01
Harga penutupan terendah: $15.37 pada 1990-01-01
Harga penutupan terendah: $15.37 pada 1990-01-01
Sejarah harga saham Takeda Pharmaceutical Company Limited dari 1990 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 16.58% |
| 2025 | 9.81% |
| 2024 | -4.74% |
| 2023 | -6.93% |
| 2022 | 10.67% |
| 2021 | -25.73% |
| 2020 | -8.85% |
| 2019 | 17.44% |
| 2018 | -38.14% |
| 2017 | 35.62% |
| 2016 | -15.67% |
| 2015 | 15.94% |
| 2014 | -13.88% |
| 2013 | 6.22% |
| 2012 | 10.14% |
| 2011 | -12.31% |
| 2010 | 13.40% |
| 2009 | -15.52% |
| 2008 | -16.70% |
| 2007 | -10.91% |
| 2006 | 20.85% |
| 2005 | 12.27% |
| 2004 | 25.62% |
| 2003 | -3.39% |
| 2002 | -8.53% |
| 2001 | -25.89% |
| 2000 | 8.44% |
| 1999 | 100.05% |
| 1998 | 14.68% |
| 1997 | 57.21% |
| 1996 | 45.92% |
| 1995 | 33.20% |
| 1994 | 4.32% |
| 1993 | -8.10% |
| 1992 | -2.51% |
| 1991 | -23.26% |
| 1990 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $212.49 | 24.09% |
CH
|
|
| $7.02 | -23.31% |
CN
|
|
| $18.32 | -4.62% |
IN
|
